Answers are grounded in this paper and cite their sources.
Pulse IV methylprednisolone therapy is the intermittent administration of supraphysiological quantities of the drug to enhance its therapeutic effects while reducing its toxic effects. 1 A typical pulse regimen ranges from 500 to 1000 mg IV daily for 2-4 consecutive days. 1,2 It has been suggested that methylprednisolone may cause an acute increase in serum creatinine (SCr), which can be misinterpreted as a clinical indication of worsening renal function. A proposed mechanism for this effect is catabolic degeneration of protein and loss of muscle tissue induced by steroid therapy. 3 However, the relation between pulse therapy and acute change in SCr after drug administration is not well defined. Sakemi and others 4 conducted a retrospective analysis of 56 patients with renal or collagen disease receiving 3 consecutive pulses of methylprednisolone 1000 mg IV daily. They found that the mean SCr increased significantly 1 day after the last dose and hypothesized that the observed effect depended on clinical status. Liu and others 5 conducted a prospective study involving 49 patients with collagen vascular disease who received methylprednisolone 1000 mg IV daily for 3 consecutive days. In that study, there was no clinically significant change in SCr 1 day after the last dose. ther literature examining the relation between consecutive pulse doses of steroid and acute change in SCr after drug administration is limited, especially for patients without baseline renal impairment.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: